| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/16/2012 | WO2012020368A1 Olmesartan formulations |
| 02/16/2012 | WO2012020123A2 Neuropilin as a biomarker for bevacizumab combination therapies |
| 02/16/2012 | WO2012019437A1 Bladder cancer tumor marker, antibiotic and application thereof |
| 02/16/2012 | WO2002085309A9 Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent |
| 02/16/2012 | US20120041524 Compositions for Providing Vitamin D Year Round and Uses Thereof |
| 02/16/2012 | US20120041176 Ucp4 |
| 02/16/2012 | US20120041010 Pharmaceutical combination of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3r,5s)-3,5-dihydroxyhept-6-enoic acid and candesartan |
| 02/16/2012 | US20120041006 Compositions for Raising Uric Acid Levels and Methods of Using the Same |
| 02/16/2012 | US20120040994 THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDIN |
| 02/16/2012 | US20120040943 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 02/16/2012 | US20120040925 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 02/16/2012 | US20120040893 Modification of feeding behaviour |
| 02/16/2012 | US20120040012 Therapeutic stem cell nutrient composition and uses thereof |
| 02/16/2012 | US20120039987 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof |
| 02/16/2012 | US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor |
| 02/16/2012 | US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 02/16/2012 | US20120038073 Spray drying methods and related compositions |
| 02/16/2012 | CA2806447A1 Neuropilin as a biomarker for bevacizumab combination therapies |
| 02/15/2012 | EP2417985A1 Mitochondrial function-improving agent |
| 02/15/2012 | EP2417974A1 Combination therapy for treatment of immune disorders |
| 02/15/2012 | EP2416794A1 Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (hiv) or hepatitis c |
| 02/15/2012 | EP2416788A2 Coupled identification and treatment of cancer |
| 02/15/2012 | EP2416773A1 Checkpoint kinase 1 inhibitors for potentiating dna damaging agents |
| 02/15/2012 | EP2416772A1 Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent |
| 02/15/2012 | EP2416771A2 Methods and compositions of pi-3 kinase inhibitors for treating fibrosis |
| 02/15/2012 | EP2416766A2 Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent |
| 02/15/2012 | EP2416661A1 Inhibitors of bacterial type iii secretion system |
| 02/15/2012 | EP1488795B1 Remedies for lung cancer |
| 02/15/2012 | CN1942472B 回折拟态及其相关方法 Mimicry and related methods folded back |
| 02/15/2012 | CN1871086B 金属胶体溶液 Metal colloid solution |
| 02/15/2012 | CN102355901A Compound for the treatment of tuberculosis |
| 02/15/2012 | CN102349997A Diagnosis and prevention of cancer cell invasion |
| 02/15/2012 | CN102349923A Use of L-carnitine and glucose for the treatment of cardiovascular diesases |
| 02/15/2012 | CN102349873A Pharmaceutical compositions based on idazoxan salt or one of the polymorphs thereof |
| 02/15/2012 | CN101854919B 用于治疗肿瘤疾病的组合物 For the treatment of neoplastic diseases compositions |
| 02/15/2012 | CN101822841B 有机胺衍生物作为小分子药物脑靶向修饰基团的用途 Organic amine derivatives as small molecule drugs targeting the brain uses a modified group |
| 02/15/2012 | CN101822642B 一种载有抗肿瘤血管生成药物的多肽修饰的隐形纳米粒及其应用 A carrier with anti-angiogenesis drugs stealth nanoparticles modified polypeptide and its application |
| 02/15/2012 | CN101785865B pH响应型两亲接枝聚膦腈给药胶束及其制备方法 pH-responsive amphiphilic graft polyphosphazene micelles and preparation method of administration |
| 02/15/2012 | CN101528213B 莫达非尼和h3受体拮抗体或反向激动剂的组合 Modafinil and h3 receptor antagonists or inverse agonists in combination |
| 02/15/2012 | CN101172099B 稳定等渗的冻干蛋白质制剂 Stable lyophilized protein formulations isotonic |
| 02/14/2012 | US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/14/2012 | US8114972 Tumor and infectious disease therapeutic compositions |
| 02/14/2012 | US8114965 Compositions of PSMA antibodies |
| 02/14/2012 | US8114913 Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with DHEA for the treatment of smallpox |
| 02/14/2012 | US8114896 Method and composition for potentiating an opiate analgesic |
| 02/14/2012 | US8114879 Piperazine derivatives useful as CCR5 antagonists |
| 02/14/2012 | US8114840 Medicament containing activated antithrombin III |
| 02/14/2012 | US8114831 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 02/14/2012 | US8114603 collecting a blood sample from the subject; andmeasuring the levels of Triggering Receptor Expressed on Myeloid cells (TREM-1) splice variant protein in sample, a decrease in the levels of TREM-1 splice variant indicates an inflammatory response |
| 02/14/2012 | US8114437 Solvent/polymer solutions as suspension vehicles |
| 02/14/2012 | US8114435 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID |
| 02/14/2012 | US8114427 Biologically active implants |
| 02/14/2012 | US8114419 Nucleic acid compositions for stimulating immune responses |
| 02/14/2012 | US8114418 Chimeric immunomodulatory compounds and methods of using the same—IV |
| 02/14/2012 | US8114397 Stabilized bacterial formulation |
| 02/14/2012 | CA2570406C Use of botulinum toxin for treating pelvic pain |
| 02/14/2012 | CA2402160C Heparinase iii and uses thereof |
| 02/09/2012 | WO2012018704A1 Use of teriflunomide for treating multiple sclerosis |
| 02/09/2012 | WO2012018145A2 Agent for improving quality of life |
| 02/09/2012 | WO2012018115A1 Composition for regeneratng normal tissue from fibrotic tissue |
| 02/09/2012 | WO2012017700A1 Method for screening chronic inflammation suppression agent or cancer metastasis suppression agent having inhibition of bonding of emmprin and s100a9 as indicator |
| 02/09/2012 | US20120035352 6-11 Bicyclic Ketolide Derivatives |
| 02/09/2012 | US20120035179 Modulators of atp-binding cassette transporters |
| 02/09/2012 | US20120035145 Methods of treating multiple myeloma using melphalan, prednisone and lenalidomide |
| 02/09/2012 | US20120035121 Antibiotic product, use and formulation thereof |
| 02/09/2012 | US20120034689 Mycobacterial antigens expressed during latency |
| 02/09/2012 | US20120034609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 02/09/2012 | US20120034292 Composition For Transdermal Delivery Of Fentanyl |
| 02/09/2012 | US20120034217 Anti-neoplastic compositions comprising extracts of black cohosh |
| 02/09/2012 | US20120034214 Methods and kits for determining the prognosis of pulmonary sarcoidosis |
| 02/09/2012 | US20120034213 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 02/09/2012 | US20120034184 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 02/09/2012 | CA2807149A1 Novel treatment of prostate carcinoma |
| 02/08/2012 | EP2415876A1 Highly sensitive detection method for highly virulent oral cavity bacteria |
| 02/08/2012 | EP2415868A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody |
| 02/08/2012 | EP2415483A1 Single dose use of cd20-specific binding molecules |
| 02/08/2012 | EP2415475A2 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum |
| 02/08/2012 | EP2415473A1 Oral Care Compositions Containing Combinations of Anti-Bacterial and Host-Response Modulating Agents |
| 02/08/2012 | EP2413970A2 New therapeutic approaches for treating neuroinflammatory conditions |
| 02/08/2012 | EP2413942A1 Use of ribose in first response to acute myocardial infarction |
| 02/08/2012 | EP2413936A1 Co-crystal of etravirine and nicotinamide |
| 02/08/2012 | EP2413934A1 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response |
| 02/08/2012 | EP2413925A1 Satiety-inducing composition |
| 02/08/2012 | EP2413922A1 Antibacterial composition comprising 4 -isopropyl-3-methylpheno and zinc ions |
| 02/08/2012 | EP2413921A1 4 -isopropyl-3-methylphenol for the treatment of inflammation |
| 02/08/2012 | EP2234611B1 Composition for treating sterile inflammation |
| 02/08/2012 | EP1545557B1 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 02/08/2012 | EP1543165B1 Assays for assembly of ebola virus nucleocapsids |
| 02/08/2012 | CN1652757B Edg受体结合剂在癌症中的应用 Edg receptor binding agents in cancer of the |
| 02/08/2012 | CN102343092A Drug carrier and drug carrier kit for inhibiting fibrosis |
| 02/08/2012 | CN102343091A Ezrin phosphorylation-based material and application thereof |
| 02/08/2012 | CN102342938A Methods and compositions for treatment and management of cancers |
| 02/08/2012 | CN101810860B 一种有抗肿瘤协同增效作用的药物组合物 A kind of synergistic anti-tumor pharmaceutical composition |
| 02/08/2012 | CN101804064B 二氢槲皮素及糖苷类化合物在制备抗耐药菌药物中的用途 Dihydro quercetin and glycosides in the manufacture of a medicament for the anti-drug-resistant |
| 02/08/2012 | CN101716349B 一种用于栓塞治疗和止痛的药物组合物及其制备方法 An embolization and analgesic pharmaceutical composition and its preparation method |
| 02/08/2012 | CN101310772B 用于诱导神经发生的氧化氮供体 For nitric oxide donor-induced neurogenesis |
| 02/07/2012 | US8110683 Piperidinyl compounds that selectively bind integrins |
| 02/07/2012 | US8110598 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 02/07/2012 | US8110587 Aryl ureas as kinase inhibitors |
| 02/07/2012 | US8110565 Of the ACE inhibitor ramipril; controlling the melting point by mixing with the free acid with the ramipril ethyl or methyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |